-
by Shopify API
The World Duchenne Organization is thrilled to announce that registrations are now open for the Duchenne Care Conference 2025. The online confe...
-
by Shopify API
CAMBRIDGE, Mass., March 18, 2025 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, share...
-
by Shopify API
Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating U...
-
by Shopify API
- Trial met primary endpoint of reduction in circulating levels of creatine kinase (CK), a biomarker associated with skeletal muscle damage, i...
-
by Shopify API
Dear Members of the Duchenne Community,
Today, Percheron Therapeutics, a public company registered in Australia and focused on developing treat...
-
by Shopify API
Australian Government bans genetic discrimination in life insurance: A big win for preventive health
Following the recommendations of a r...
-
by Shopify API
Philips after consultation with TGA is conducting an Urgent Product Defect Correction for the Philips BiPAP A40 Pro Ventilator, BiPAP A40 E...
-
by Shopify API
Philips after consultation with TGA is conducting an update to the Urgent Product Defect Alert of Philips BiPAP A30, BiPAP A30 EFL, BiPAP A...
-
by Shopify API
DOWNLOAD PDF
-
by Shopify API
Pfizer gene therapy clinical trials commence in Australia! The first Australian boy has been screened as part of the Pfizer gene therapy clinica...
-
by Shopify API
The long awaited Federal Parliamentary Inquiry report into Approval Process for New Drugs and Novel Technologies has now been released. The reco...
-
by Shopify API
Save Our Sons Duchenne Foundation has just written a submission on behalf of our community to the Senate Standing Committee on Community Affairs...
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device